Design, synthesis, characterization and in vivo studies of some hydroxylated chalcone derivatives as hypoglycemic agents

Journal Title: Journal of Pharmacovigilance and Drug Research - Year 2020, Vol 1, Issue 20201103

Abstract

Low molecular weight ligands (LMWL) have citadel reputation in the modulation of numerous therapeutic targets as a result of their smart uniqueness. The hydroxylated chalcone derivatives have been reported to be therapeutic agents owing to their capability to demonstrate multifarious pharmacological activities, however, their potential in lowering of blood glucose level is not yet explored fully. Corresponding aldehydes and acetophenones were made to react in an alcoholic basic medium to produce the desired chalcone scaffolds. The anti-hyperglycemic potentials of the derivatives were studied using the streptozotocin-induced diabetic rat model. Compounds 3d, 3f, 3g, 3h, and 3j demonstrated excellent anti-hyperglycemic activity. Chalcone 3d, having an ortho-methoxy substituent in B-ring, displayed the highest hypoglycemic potential with a 26.9% lowering of blood glucose level compared to standard acarbose which exhibited a 34.7% reduction. Compounds 3a, 3c, and 3e showed the lowest activity. The study revealed the potential of chalcone scaffolds in lessening the blood glucose level by 7.1% to 26.9%. The ortho-position was observed to be high opportunistic for inducing the hypoglycemia activity as compared to para-position and para-position is in turn advantageous to the meta-position. The role of various substituents in modulating this enzyme function was studied. The electron-donating groups were found to be effectual for modulation of the anti-diabetic target compared to electron-withdrawing groups.

Authors and Affiliations

Animeshchandra G. M. Haldar 1, Santosh Subhash Chhajed 2, Akanksha Ravindra Ugale 2, Sanjay J. Kshirsagar 2, Kanhaiya Murlidhar Dadure 3, Debarshi Kar Mahapatra 4*

Keywords

Related Articles

Design, synthesis, characterization and in vivo studies of some hydroxylated chalcone derivatives as hypoglycemic agents

Low molecular weight ligands (LMWL) have citadel reputation in the modulation of numerous therapeutic targets as a result of their smart uniqueness. The hydroxylated chalcone derivatives have been reported to be therapeu...

Cutaneous Adverse Drug Reactions in a Tertiary Care Hospital: An Observational Study

Cutaneous adverse drug reactions (CADRs) are one of the most common ADRs caused by drugs causing a lot of morbidity and mortality. The overall incidence of CADRs in developed countries is 1-3 %, while that in the develop...

A Review on Potential Drug Delivery System as a Treatment of Intercellular Bacterial Infection

Intracellular bacterial pathogens are hard to treat because of the inability of conventional antimicrobial agents belonging to widely used classes, like aminoglycosides and β-lactams, fluoroquinolones, or macrolides to p...

Nevirapine induced Stevens Johnson Syndrome

A 56-year-old male patient presented with a complaint of lesions all over the body with a burning sensation for 4 days. He was on an ART regimen, containing zidovudine, lamivudine, and efavirenz combination for 4 years....

Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide

Dytor plus tablet is a fixed-dose combination of torsemide and spironolactone used for generalized edema. TEN is a serious, potentially life-threatening dermatological disorder. Here we present a case report of a 47-year...

Download PDF file
  • EP ID EP690853
  • DOI 10.5281/zenodo.4016731
  • Views 142
  • Downloads 0

How To Cite

Animeshchandra G. M. Haldar 1, Santosh Subhash Chhajed 2, Akanksha Ravindra Ugale 2, Sanjay J. Kshirsagar 2, Kanhaiya Murlidhar Dadure 3, Debarshi Kar Mahapatra 4* (2020). Design, synthesis, characterization and in vivo studies of some hydroxylated chalcone derivatives as hypoglycemic agents. Journal of Pharmacovigilance and Drug Research, 1(20201103), -. https://europub.co.uk/articles/-A-690853